Premium
A burst of speed for neurological research
Author(s) -
Ullman Kurt
Publication year - 2013
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.23983
Subject(s) - annals , citation , computer science , library science , history , classics
Through a cooperative venture between the National Institute of Neurological Disorders and Stroke (NINDS) and 27 research institutions nationwide, a new clinical trials network has been established. The goal of the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) encourages collaboration among academia, industry, and foundations while accelerating drug development for neurological disorders. “It has been observed that current research processes are not as streamlined as they could be,” says Petra Kaufmann, MD, MSc, Director of the Office of Clinical Research at NINDS and an early proponent of the concept. “For even small trials, the infrastructure had to be built, people had to enter into multiple subcontracts, and each center had its own Institutional Review Board (IRB). We thought it would be great if some of these efforts, as well as the time and money spent on them, could be redirected toward scientific and clinical uses.”